Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sachi Kanazawa"'
Autor:
Hideki Maki, Kenji Yamawaki, Toshiaki Aoki, Daiki Nagamatsu, Ryosuke Watari, Motohiro Fujiu, Hiroki Kusano, Yuya Hirakawa, Kazuo Komano, Sachi Kanazawa, Emi Kashiwagi, Naoki Kohira, Satoru Shibuya, Soichiro Sato, Tomoyuki Kawachi, Jun Sato, Katsuki Yokoo
Publikováno v:
Journal of medicinal chemistry. 64(13)
Coadministration of β-lactam and β-lactamase inhibitor (BLI) is one of the well-established therapeutic measures for bacterial infections caused by β-lactam-resistant Gram-negative bacteria, whereas we have only two options for orally active BLI,
Publikováno v:
Antimicrobial Agents and Chemotherapy
Activities of cefiderocol under simulated human plasma concentrations at the recommended dosing regimen of 2 g every 8 h with a 3-h infusion were evaluated using an in vitro chemostat model. Against a total of 6 meropenem-resistant Gram-negative stra
Autor:
Sachi Kanazawa, Masaaki Izawa, Takahiro Yamaguchi, Takafumi Hara, Tsukasa Horiyama, Masakatsu Tsuji, Takafumi Sato, Hideki Maki
Publikováno v:
Journal of Infection and Chemotherapy. 21:381-384
To compare the risk of acquiring in vitro resistance between doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli, the in vitro frequency of resistance was determined. Four strains carrying multiple β-lactamases such as blaOX
Autor:
Tsukasa Ito-Horiyama, Yoshinori Yamano, Masakatsu Tsuji, Sachi Kanazawa, Takafumi Sato, Naoki Kohira
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Carbapenemase-producing Enterobacteriaceae (CPE) have been spreading worldwide and are a great concern among health care settings ([1][1]). Intriguingly, IMP-6 (encoded by the bla IMP-6 gene), one of the IMP-type metallo-carbapenemases, has been repo
Autor:
Sachi, Kanazawa, Takafumi, Sato, Naoki, Kohira, Tsukasa, Ito-Horiyama, Masakatsu, Tsuji, Yoshinori, Yamano
Publikováno v:
Antimicrobial agents and chemotherapy. 61(7)
Autor:
Takafumi, Hara, Takafumi, Sato, Tsukasa, Horiyama, Sachi, Kanazawa, Takahiro, Yamaguchi, Hideki, Maki
Publikováno v:
The Japanese journal of antibiotics. 68(2)
The prevalence of extended-spectrum β-lactamase (ESBL) in Enterobacteriaceae has been increasing worldwide. The aims of this study were to determine the prevalence of ESBLs among clinical isolates of Escherichia coli obtained from 2000 to 2010 in Ja
Autor:
Shuhei Matsumoto, Yoshinori Yamano, Takafumi Sato, Sachi Kanazawa, Masakatsu Tsuji, AQ Nakamura
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Tsukasa Horiyama, Takafumi Hara, Takafumi Sato, Hideki Maki, Takahiro Yamaguchi, Sachi Kanazawa
Publikováno v:
Journal of medical microbiology. 64(Pt 5)
Clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca collected from 20 Japanese medical facilities between 2000 and 2010 were analysed to evaluate the mechanisms of resistance and antibacterial susceptibilities to 14 antimicrobials. Over
Autor:
Yoshinori Yamano, Rio Nakamura, Shuhei Matsumoto, Takafumi Sato, Masakatsu Tsuji, Sachi Kanazawa
Publikováno v:
Open Forum Infectious Diseases
Background Cefiderocol (S-649266), a novel siderophore cephalosporin, shows potent activity against carbapenem-resistant Gram-negative bacilli. In the cefiderocol global surveillance study that focused on carbapenem-resistant Gram-negatives (SIDERO-C
1106. Evaluation of Penetration of Cefiderocol into Cerebrospinal Fluid Using a Rat Meningitis Model
Autor:
Takemura, Miki, Kanazawa, Sachi, Kohira, Naoki, Aoe, Yuki, Morimoto, Atsushi, Horiuchi, Kana, Inoue, Yuji, Yamano, Yoshinori
Publikováno v:
Open Forum Infectious Diseases
Background Central nervous system (CNS) infections caused by Gram-negative bacteria (GNB) are sometimes hard to treat due to antibiotic resistance and difficulty with penetration into cerebrospinal fluid (CSF). Cefiderocol (CFDC) which was approved b